Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Dragon to build new nanotechnology packaging plant
Dragon International Group Corp a manufacturer and distributor of specialty paper products and packaging materials, operating within central and eastern China, plans to build a new manufacturing facility which will be utilised to make new packaging products developed through the use of nanotechnologies The new plant will manufacture products for th...
Zydus and Mayne build new plant to manufacture oncology products in India
Zydus Cadila and Mayne Pharma, an injectable specialty pharmaceuticals company based in Australia signed a joint venture agreement to set up a 5050 joint venture company to manufacture generic injectable, cytotoxic anticancer medicines and active pharmaceutical ingredients API for global markets The two companies will share equally the investment...
Dishman Pharma manufacturing facility in Shanghai
Dishman Pharmaceuticals and Chemicals Ltd is setting up a new greenfield manufacturing facility in Shanghai Chemical Industry Park at a cost of Rs 45 crore $10 million The project, which is expected to go on stream by the end of 2007, will offer the company a major advantage in the cost of production since the cost of utilities in China is half the...
Novartis's new strategic biomedical R&D center in Shanghai
Integrated Research Development center, the first Novartis site of its kind in China Primary focus on infectious causes of cancer endemic to China and Asia Center will capitalize on talent in emerging life sciences cluster in Shanghai Initial investment of USD 100 million to create Shang
GlaxoSmithKline's New R&D Plant in Singapore
GlaxoSmithKline GSK is investing US$ 115 million in a new RD pilot plant at its Global Manufacturing Supply GMS site in Jurong, Singapore The construction of the new plant started in 2005 and is scheduled to become operational in 2007 The pilot plant is being set up to increase production capacity and accommodate the companys new chemical entities...
Lonza Group and Bio*One's Custom Biopharmaceuticals Plant in Singapore
PROJECTS Lonza Group and BioOnes Custom Biopharmaceuticals Plant in Singapore Lonza
Inno Biologics' cGMP Biopharmaceutical Manufacturing Plant
Inno Biologics, a Malaysian governmentbacked company, is in the process of assembling the countrys first cGMP modular biopharmaceutical production plant that was shipped from Pharmaplan International, Germany The facility, which will be finished in mid2006 and operational by end 2006, is funded by loans and government funds that amount to USD$26 mi...
Novo Nordisk Expands Production Plant in China
Novo Nordisk, the Denmarkbased healthcare and diabetic care company is building its new assembling and production facility in Tianjing, the companys production base in China The plant, being promoted as part of the companys expansion programme in China, will be commissioned in the middle of 2006 It will meet the growing demand for FlexPen, NovoPen...
